vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and ON Semiconductor (ON). Click either name above to swap in a different company.

ON Semiconductor is the larger business by last-quarter revenue ($1.6B vs $1.0B, roughly 1.5× Everus Construction Group, Inc.). ON Semiconductor runs the higher net margin — 16.4% vs 5.5%, a 11.0% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs -10.0%). ON Semiconductor produced more free cash flow last quarter ($372.4M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs -12.3%).

Fairchild Semiconductor International, Inc. was an American semiconductor company based in San Jose, California. It was founded in 1957 as a division of Fairchild Camera and Instrument by the "traitorous eight" who defected from Shockley Semiconductor Laboratory. It became a pioneer in the manufacturing of transistors and of integrated circuits. Schlumberger bought the firm in 1979 and sold it to National Semiconductor in 1987; Fairchild was spun off as an independent company again in 1997. I...

ECG vs ON — Head-to-Head

Bigger by revenue
ON
ON
1.5× larger
ON
$1.6B
$1.0B
ECG
Growing faster (revenue YoY)
ECG
ECG
+43.1% gap
ECG
33.2%
-10.0%
ON
Higher net margin
ON
ON
11.0% more per $
ON
16.4%
5.5%
ECG
More free cash flow
ON
ON
$348.9M more FCF
ON
$372.4M
$23.5M
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
-12.3%
ON

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ECG
ECG
ON
ON
Revenue
$1.0B
$1.6B
Net Profit
$55.3M
$255.0M
Gross Margin
11.6%
37.9%
Operating Margin
6.8%
17.0%
Net Margin
5.5%
16.4%
Revenue YoY
33.2%
-10.0%
Net Profit YoY
60.4%
-32.9%
EPS (diluted)
$1.09
$0.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
ON
ON
Q4 25
$1.0B
$1.6B
Q3 25
$986.8M
$1.5B
Q2 25
$921.5M
$1.4B
Q1 25
$826.6M
Q4 24
$759.6M
$1.7B
Q3 24
$761.0M
$1.8B
Q2 24
$703.4M
$1.7B
Q1 24
$625.7M
$1.9B
Net Profit
ECG
ECG
ON
ON
Q4 25
$55.3M
$255.0M
Q3 25
$57.0M
$170.3M
Q2 25
$52.8M
$-486.1M
Q1 25
$36.7M
Q4 24
$34.5M
$379.9M
Q3 24
$41.8M
$401.7M
Q2 24
$39.0M
$338.2M
Q1 24
$28.2M
$453.0M
Gross Margin
ECG
ECG
ON
ON
Q4 25
11.6%
37.9%
Q3 25
12.6%
37.6%
Q2 25
13.0%
20.3%
Q1 25
11.2%
Q4 24
11.4%
45.2%
Q3 24
11.8%
45.4%
Q2 24
12.6%
45.2%
Q1 24
11.9%
45.8%
Operating Margin
ECG
ECG
ON
ON
Q4 25
6.8%
17.0%
Q3 25
7.3%
13.2%
Q2 25
7.9%
-39.7%
Q1 25
6.2%
Q4 24
6.1%
23.7%
Q3 24
7.1%
25.3%
Q2 24
7.3%
22.4%
Q1 24
6.2%
28.2%
Net Margin
ECG
ECG
ON
ON
Q4 25
5.5%
16.4%
Q3 25
5.8%
11.6%
Q2 25
5.7%
-33.6%
Q1 25
4.4%
Q4 24
4.5%
22.1%
Q3 24
5.5%
22.8%
Q2 24
5.5%
19.5%
Q1 24
4.5%
24.3%
EPS (diluted)
ECG
ECG
ON
ON
Q4 25
$1.09
$0.63
Q3 25
$1.11
$0.41
Q2 25
$1.03
$-1.15
Q1 25
$0.72
Q4 24
$0.68
$0.88
Q3 24
$0.82
$0.93
Q2 24
$0.76
$0.78
Q1 24
$0.55
$1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
ON
ON
Cash + ST InvestmentsLiquidity on hand
$2.9B
Total DebtLower is stronger
$281.5M
$3.4B
Stockholders' EquityBook value
$629.8M
$7.9B
Total Assets
$1.7B
$13.0B
Debt / EquityLower = less leverage
0.45×
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
ON
ON
Q4 25
$2.9B
Q3 25
$2.8B
Q2 25
$3.0B
Q1 25
Q4 24
$3.0B
Q3 24
$553.0K
$2.8B
Q2 24
$2.7B
Q1 24
$2.6B
Total Debt
ECG
ECG
ON
ON
Q4 25
$281.5M
$3.4B
Q3 25
$285.1M
$3.4B
Q2 25
$288.6M
$3.4B
Q1 25
$292.1M
Q4 24
$295.6M
$3.4B
Q3 24
$3.4B
Q2 24
$3.4B
Q1 24
$3.4B
Stockholders' Equity
ECG
ECG
ON
ON
Q4 25
$629.8M
$7.9B
Q3 25
$573.0M
$7.9B
Q2 25
$514.4M
$8.0B
Q1 25
$460.2M
Q4 24
$422.6M
$8.8B
Q3 24
$453.3M
$8.6B
Q2 24
$490.0M
$8.3B
Q1 24
$464.3M
$8.1B
Total Assets
ECG
ECG
ON
ON
Q4 25
$1.7B
$13.0B
Q3 25
$1.6B
$13.1B
Q2 25
$1.5B
$13.3B
Q1 25
$1.4B
Q4 24
$1.3B
$14.1B
Q3 24
$1.3B
$13.9B
Q2 24
$13.7B
Q1 24
$13.5B
Debt / Equity
ECG
ECG
ON
ON
Q4 25
0.45×
0.43×
Q3 25
0.50×
0.43×
Q2 25
0.56×
0.42×
Q1 25
0.63×
Q4 24
0.70×
0.38×
Q3 24
0.39×
Q2 24
0.41×
Q1 24
0.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
ON
ON
Operating Cash FlowLast quarter
$48.2M
$418.7M
Free Cash FlowOCF − Capex
$23.5M
$372.4M
FCF MarginFCF / Revenue
2.3%
24.0%
Capex IntensityCapex / Revenue
2.4%
3.0%
Cash ConversionOCF / Net Profit
0.87×
1.64×
TTM Free Cash FlowTrailing 4 quarters
$90.0M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
ON
ON
Q4 25
$48.2M
$418.7M
Q3 25
$76.2M
$184.3M
Q2 25
$25.3M
$602.3M
Q1 25
$7.1M
Q4 24
$579.7M
Q3 24
$78.9M
$465.8M
Q2 24
$362.2M
Q1 24
$21.9M
$498.7M
Free Cash Flow
ECG
ECG
ON
ON
Q4 25
$23.5M
$372.4M
Q3 25
$65.7M
$106.1M
Q2 25
$12.3M
$454.7M
Q1 25
$-11.4M
Q4 24
$434.8M
Q3 24
$60.9M
$293.6M
Q2 24
$207.7M
Q1 24
$12.6M
$276.3M
FCF Margin
ECG
ECG
ON
ON
Q4 25
2.3%
24.0%
Q3 25
6.7%
7.2%
Q2 25
1.3%
31.5%
Q1 25
-1.4%
Q4 24
25.2%
Q3 24
8.0%
16.7%
Q2 24
12.0%
Q1 24
2.0%
14.8%
Capex Intensity
ECG
ECG
ON
ON
Q4 25
2.4%
3.0%
Q3 25
1.1%
5.3%
Q2 25
1.4%
10.2%
Q1 25
2.2%
Q4 24
8.4%
Q3 24
2.4%
9.8%
Q2 24
8.9%
Q1 24
1.5%
11.9%
Cash Conversion
ECG
ECG
ON
ON
Q4 25
0.87×
1.64×
Q3 25
1.34×
1.08×
Q2 25
0.48×
Q1 25
0.19×
Q4 24
1.53×
Q3 24
1.89×
1.16×
Q2 24
1.07×
Q1 24
0.77×
1.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

ON
ON

Industrial Segment$426.3M27%
Other End Markets Segment$337.3M22%
Intelligent Sensing Segments$284.0M18%
Direct Customers$282.4M18%
Intelligent Sensing Group$230.0M15%

Related Comparisons